Litigation Details for Self Insured Schools of California v. Allergan, Inc (E.D.N.Y 2018)
✉ Email this page to a colleague
Self Insured Schools of California v. Allergan, Inc (E.D.N.Y 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-03-01 |
| Court | District Court, E.D. New York | Date Terminated | 2023-08-01 |
| Cause | 15:1 Antitrust Litigation | Assigned To | Nina Gershon |
| Jury Demand | Plaintiff | Referred To | Lois Bloom |
| Parties | DIRECT PURCHASER CLASS PLAINTIFFS | ||
| Patents | 9,248,191 | ||
| Attorneys | Nicomedes Sy Herrera | ||
| Firms | Girard Sharp LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Self Insured Schools of California v. Allergan, Inc
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Self Insured Schools of California v. Allergan, Inc (E.D.N.Y 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-01-05 | 1 | 2016 as U.S. Patent No. 9,248,191 (“the ’191 patent”). These are the 12 second wave patents at issue here…dated Apr. 1, 2014), and US 9,248,191 (dated Feb. 2, 6 2016). As of September 8, 2017, Allergan purports…Ding I patent. 6 63. The second patent, U.S. Patent No. 5,981,607 (“the ’607 patent” or “the…protected by the U.S. Patent No. 5,474,979 the 28 “’979 Patent” or “Ding I patent”). The PTO issued the… the issuance of a patent 24 does not mean that the patent is valid. Many patents issued by the PTO | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
